There are two continuing education programs available on this website: The original ER/LA opioids REMS program (3 contact hours) and a 2016 Update (2 contact hours).
With respect to the original program:
On July 9, 2012 the Food and Drug Administration (FDA) approved a Risk Evaluation and Mitigation Strategy (REMS) for extended release (ER) and long acting (LA) opioid medications.
Founded in June, 2010, the Collaborative on REMS Education (CO*RE). a multi disciplinary team of 10 partners and 3 cooperating organizations, has designed a core curriculum based on needs assessment, practice gaps, clinical competencies, and learner self assessment to meet the requirements of the FDA REMS Blueprint
Please Read all Information Below (for specific information on the New Update 2016 program click on that tab in the menu above)
The ER/LA Opioids REMS Program
This is a continuing education program for APNs that is approved for 3 contact hours in pharmacology.
Release Date: November 1, 2014
Expiration Date: October 31, 2017
The Nurse Practitioner Healthcare Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is also intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the U.S. Food & Drug Administration (FDA)
Requirements for successful completion of this CNE activity include downloading the handout (after registering), viewing the introduction and all six unit videos (see video information table at bottom of page), answering the assessment questions embedded at the end of each Unit, and completing an online program evaluation.
Content Development/Planner/Reviewer Disclosures
The information presented in this program is solely for educational purposes and should not be construed as specific instructions for the diagnosis or treatment of patients. Utilization of any information, derived from this program, in patient care remains strictly the professional responsibility of the health care provider. The health care provider is further advised to: (1) ascertain current FDA status of each drug and (2) consult current drug information guides, manufacturer product information or package inserts regarding the proper use, dosages, dosing schedules, contraindications, warnings and other pertinent prescribing and safety information. The Faculty (Alan Agins, Jody Agins, Wendy Wright) disclaim any liability, loss, injury or damage incurred as a consequence, directly or indirectly, from the use and application of any of the contents of this program. During the "Program" there may be occasional mention of proprietary or brand-name drugs. The mention or appearance of a specific proprietary product name should not be construed by the viewer that the Faculty, NPHF or CO*RE endorse or have specific bias toward that product or its manufacturer. Similarly, the absence of mention of a specific brand name should not imply that the product is deemed inferior to others in its class.
Video Information Table
Presented by Nurse Practitioner Healthcare Foundation, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to imrpove pain management and prevent adverse outcomes.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesics REMS Program Companies (RPC).
Please see www.er-la-opioidREMS.com for a listing of the member companies.
This activity is intended to be fully compliant with the ER/LA Opioid Analgesics REMS
education requirements issued by the U.S. Food & Drug Administration.
Video production and editing, website conception and implementation by PRN Associates, Ltd
(A.Agins, Ph.D. - Pharmacology One-on-One)
Update 2016 - course development, script, video, editing, web implementation by PRN Associates, Ltd (A.Agins, Ph.D.)
Website design and development by Black Stone, LLC (Villy Toma, Andrei Velicu )
Wendy Wright is a 1992 graduate of the Adult Primary Care Nurse Practitioner program at Simmons College in Boston, Massachusetts and completed a family nurse practitioner post-master's program in 1995. She is an adult and family nurse practitioner and the owner of two nurse practitioner owned and operated clinics within New Hampshire named: Wright & Associates Family Healthcare @ Amherst and @ Concord. In addition, she is a Partner with Partners in Healthcare Education, a medical education company. She is the recipient of numerous awards and was chosen by the American Academy of Nurse Practitioners as the 1999 recipient of the New Hampshire State Excellence Award. In addition, she received the 2009 NH Nurse Practitioner of the Year award and in 2005, she was inducted as a Fellow into the American Academy of Nurse Practitioners; a position held by only 400 other nurse practitioners throughout the country.
Jody Agins received her MSN/Family Nurse Practitioner from the University of Kansas and is board certified by the ANCC in Family Practice and Gerontology. She is the founder & executive director, and practices as an NP, for Collaborative Medical Provider Group (PLLC), a consortium of private-practice clinicians in Tucson, AZ. Jody is also the Clinical Services Director for Agape Hospice and Palliative Care and is a primary care provider for CareMore Touch also in Tucson. In addition, she serves as a clinical preceptor for Family and Geriatric Nurse Practitioner students at a number of universities in Arizona. Mrs Agins is also invited to speak nationally on pain management, geriatric care and a number of other topics for various NP organizations. She is a faculty presenter for the Collaborative on REMS Education programs through the Nurse Practitioner Healthcare Foundation.
Alan Agins received a Masters in Pharmacology & Toxicology and a Ph.D. in Pharmaceutical Sciences from the University of Rhode Island. He has held faculty appointments at Brown University Medical School, Northeastern University School of Pharmacy and University of Virginia School of Nursing. During his tenure at Brown, Dr Agins was the recipient of the Dean's Teaching Excellence Award for five consecutive years. Over the past twenty years, Dr. Agins has lectured nationally on all topics of pharmacology to more than 85,000 advanced practice clinicians and allied healthcare professionals. He has authored three books, co-authored textbook chapters and has served as primary reviewer for various journals, CE monographs, textbooks and newsletters. Dr Agins recently developed and launched a continuing education website, Pharmacology One-on-One (pharm1on1.com) which became the blueprint for this NPHF /CO*RE website.
Keeping Up to Date:
Surgeon General's Call to End Opioid Crisis Turn-the-Tide Org NEW
Naloxone: Frequently Asked Questions (pdf) ( also under Unit 4 below)
Naloxone: An Opportunity for Another Chance 3/16 (link to JNP online)
CO*RE Newsletter 2016 (Feb 2016) (pdf)
General Information & Downloads
General Information (regarding ER/LA Opioid REMS)
ER/LA OPIOID REMS document - Aug 2014 (pdf)
FDA Blueprint for Prescriber Education for ER/LA Opioids Aug 2014 (pdf)
ER/LA Opioids REMS program
Opioid Risk Screening and Assessment Instruments
Opioid Risk Management
SOAPP® Monitoring Recommendations
The SOAPP® Version 1.0 Tutorial
Opioid Risk Tool (ORT)- online calculator
Opioid Risk Tool (ORT) - pdf
Code of Federal Regulations, Title 21 Section 1306: rules governing the issuance & filling of prescriptions
Controlled Substances Act: Title 21, Section 829: prescriptions
APRN Prescribing Law: A Stete-by-State Summary (July 2013)
Database of Statutes, Regulations, & Other Policies for Pain Management
Sample Informed Consent Form (DrugAbuse.gov)
Sample Informed Consent Form (IHS.gov)
Sample PPA - Patient Agreement Form (DrugAbuse.gov)
Sample PPA - Patient Agreement Form (AAFP)
Sample PPA - Patient Agreement Form (IHS.gov)
State-by-State PDMP Information (National Alliance for Model State Drug Laws - current to July 2014)
Role of Urine Drug Testing in Chronic Pain Management (Review article)
Urine Drug Testing In Chronic Pain (comprehensive review - pdf download)
Interpretation of Opiate Urine Drug Screens
Urine Drug Monitoring - Opioids (comprehensive review)
SAMHSA substance abuse treatment facility locator
SAMHSA mental health treatment facility locator
Drug Rehab - web information guide /addiction treatment facility locator
Patient Counseling Document
Patient Counseling Document Order hard copies (free, including shipping)
Serious Adverse Effects Reporting (FDA)
Disposal of Controlled Substances (Federal Register - Sept 2014)
(Opioid) Disposal Act: General Public Fact Sheet
Additional Links - Opioid Treatment Guidelines
Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain (Jan 2014)
New Review Gives High Marks to 2 of 13 Opioid Guidelines (Nov 2013)
Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain (Canadian - 2010)
Guideline for the Use of Chronic Opioid Therapy in Chronic Non-cancer Pain (APS-AAPM 2009)
Update 2016 Program - references
A New Abuse-Deterrent Opioid - Xtampza ER | The Medical Letter, Inc.
AANP - State Practice Environment
Abuse-Deterrent Opioids: A Primer for Pharmacists (good for all clinicians)
Patterns of Drug Addiction and Hidden Pain
Naloxone Accessibility Increases . . . (good for all clinicians)
Belbuca New FDA Drug Approval | CenterWatch
CDC Guideline for Prescribing Opioids for Chronic Pain
CDC guidelines checklist
CDC Opioid Prescribing Guidelines Misguided, Docs Say
Comprehensive Addiction and Recovery Act (CARA) | CADCA
Drug Overdose Immunity and Good Samaritan Laws
Drugmakers fought state opioid limits amid crisis
First Abuse-Deterrent Oxycodone IR Launched - MPR
Nurse Practitioners and Physician Assistants Prescribing Buprenorphine
Reduce Drug Abuse and Diversion with PDPMs
Questions & Answers - State Prescription Drug Monitoring Programs
PDMP - Prescribers' report card
State PDMP Websites | The PDMP Training and Technical Assistance Center
States aim to limit opioid prescriptions
The New Black Horse in the Opioid Crisis: Carfentanil
Surgeon General's Call to End Opioid Crisis Turn-the-Tide Org